Compare DNUT & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNUT | STAA |
|---|---|---|
| Founded | 1937 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Ophthalmic Goods |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 734.9M | 1.2B |
| IPO Year | 2021 | N/A |
| Metric | DNUT | STAA |
|---|---|---|
| Price | $4.58 | $25.16 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 10 |
| Target Price | $6.22 | ★ $24.56 |
| AVG Volume (30 Days) | ★ 3.1M | 1.6M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.53% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,534,272,000.00 | $230,591,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.77 | $22.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.50 | $13.50 |
| 52 Week High | $10.06 | $30.81 |
| Indicator | DNUT | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 59.61 | 49.14 |
| Support Level | $4.35 | $23.03 |
| Resistance Level | $4.75 | $26.18 |
| Average True Range (ATR) | 0.19 | 1.52 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 70.92 | 49.68 |
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.